Cultivating hope one star sperm at a time
Improved success in ART
Spermotile improves the success rates of assisted reproductive technologies such as IUI, IVF and ICSI by as much as 20%.
Reduced pain and cost
Spermotile reduces the number of cycles per patient by improving the success rate of fertilization. This reduces both the pain and the cost of the treatment.
Star sperm selection
Spermotile uses a patent-pending technology to identify the best sperms in terms of morphology, motility, kinematics and nanoscale motion patterns in a chemical-free manner.
Infertility
As infertility rates rise globally, affecting 15% of couples, the demand for ART (Assisted Reproduction Technologies) has increased. But ART is demanding — physically, psychologically, and financially — with no guarantee of success. Selecting the highest quality sperm for fertilization can improve ART outcomes.
Funding, Partners & Stakeholder
EU ERC-POC 2023
Norway- RCN Qualification 2023
Norway – RCN Verification 2024
Innovation Norway(REACH Program)
University Hospital North Norway
UiT Innovation support
TTO-Norrinova
Improve ART success rate with Spermotile
Presenting Spermotile: a game-changer in ART, aimed at boosting fertilization rates and minimizing treatment cycles. Spermotile’s groundbreaking computer-assisted semen analysis (CASA) identifies the top-quality sperms, termed ‘star sperms,’ without using harmful stains, which are then filtered by Spemotile’s non-chemical and extremely gentle patent pending technology’.
